Total Payments
$12,697
2023 Payments
$24.52
Companies
36
Transactions
792
Medicare Patients
4,539
Medicare Billing
$453,865
Payment Breakdown by Category
Food & Beverage$12,620 (99.4%)
Education$77.68 (0.6%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $12,620 | 784 | 99.4% |
| Education | $77.68 | 8 | 0.6% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Janssen Pharmaceuticals, Inc | $2,170 | 160 | $0 (2022) |
| Amarin Pharma Inc. | $1,103 | 78 | $0 (2022) |
| Novartis Pharmaceuticals Corporation | $1,072 | 64 | $0 (2022) |
| PFIZER INC. | $920.36 | 50 | $0 (2022) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $811.55 | 44 | $0 (2021) |
| Abbott Laboratories | $677.93 | 25 | $0 (2022) |
| Amgen Inc. | $598.24 | 30 | $0 (2022) |
| E.R. Squibb & Sons, L.L.C. | $529.96 | 32 | $0 (2022) |
| Gilead Sciences, Inc. | $522.18 | 68 | $0 (2018) |
| AstraZeneca Pharmaceuticals LP | $401.73 | 29 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2023 | $24.52 | 1 | Lexicon Pharmaceuticals, Inc. ($24.52) |
| 2022 | $510.07 | 27 | Amgen Inc. ($84.62) |
| 2021 | $2,673 | 146 | Amarin Pharma Inc. ($426.52) |
| 2020 | $1,858 | 116 | Janssen Pharmaceuticals, Inc ($547.03) |
| 2019 | $2,756 | 166 | PFIZER INC. ($447.04) |
| 2018 | $2,562 | 170 | Janssen Pharmaceuticals, Inc ($474.09) |
| 2017 | $2,313 | 166 | Novartis Pharmaceuticals Corporation ($336.23) |
All Payment Transactions
792 individual payment records from CMS Open Payments — Page 1 of 32
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 07/13/2023 | Lexicon Pharmaceuticals, Inc. | Inpefa (Drug) | Food and Beverage | In-kind items and services | $24.52 | General |
| Category: Inhibitor of SGLT2 and SGLT1 | ||||||
| 08/26/2022 | Regeneron Healthcare Solutions, Inc. | EVKEEZA (Biological) | Education | In-kind items and services | $18.99 | General |
| Category: CARDIOVASCULAR AND METABOLISM | ||||||
| 04/25/2022 | Abbott Laboratories | CARDIOMEMS (Device) | Food and Beverage | In-kind items and services | $17.69 | General |
| Category: Heart Failure | ||||||
| 04/07/2022 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $23.98 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 03/29/2022 | Amarin Pharma Inc. | Vascepa (Drug) | Food and Beverage | In-kind items and services | $20.06 | General |
| Category: Cardiovascular | ||||||
| 03/29/2022 | PFIZER INC. | VYNDAQEL (Drug) | Food and Beverage | In-kind items and services | $18.65 | General |
| Category: CARDIOVASCULAR | ||||||
| 03/28/2022 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $17.18 | General |
| Category: Cardiology | ||||||
| 03/24/2022 | Amarin Pharma Inc. | Vascepa (Drug) | Food and Beverage | In-kind items and services | $20.06 | General |
| Category: Cardiovascular | ||||||
| 03/23/2022 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $13.48 | General |
| Category: CARDIOVASCULAR | ||||||
| 03/17/2022 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $17.87 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 03/15/2022 | Amarin Pharma Inc. | Vascepa (Drug) | Food and Beverage | In-kind items and services | $20.06 | General |
| Category: Cardiovascular | ||||||
| 03/14/2022 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $21.97 | General |
| Category: Cardiology | ||||||
| 03/10/2022 | Esperion Therapeutics, Inc. | NEXLETOL (Drug) | Food and Beverage | In-kind items and services | $24.63 | General |
| Category: ANTILIPEMIC AGENTS | ||||||
| 03/08/2022 | SANOFI-AVENTIS U.S. LLC | MULTAQ (Drug) | Food and Beverage | In-kind items and services | $18.95 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 03/04/2022 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $15.47 | General |
| 03/02/2022 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $13.75 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 03/01/2022 | Merck Sharp & Dohme LLC | VERQUVO (Drug) | Food and Beverage | In-kind items and services | $21.46 | General |
| Category: CARDIOVASCULAR | ||||||
| 02/24/2022 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $15.75 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 02/23/2022 | E.R. Squibb & Sons, L.L.C. | — | Food and Beverage | Cash or cash equivalent | $20.33 | General |
| 02/08/2022 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $13.17 | General |
| Category: CARDIOVASCULAR | ||||||
| 02/03/2022 | Esperion Therapeutics, Inc. | NEXLETOL (Drug) | Food and Beverage | In-kind items and services | $24.56 | General |
| Category: ANTILIPEMIC AGENTS | ||||||
| 02/03/2022 | SANOFI-AVENTIS U.S. LLC | MULTAQ (Drug) | Food and Beverage | In-kind items and services | $19.18 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 02/01/2022 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $16.85 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 01/31/2022 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $16.41 | General |
| Category: Cardiovascular | ||||||
| 01/26/2022 | PFIZER INC. | VYNDAQEL (Drug) | Food and Beverage | In-kind items and services | $15.80 | General |
| Category: CARDIOVASCULAR | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 1 | 52 | 57 | $1,570 | $367.95 |
| 2022 | 7 | 369 | 415 | $39,965 | $8,687 |
| 2021 | 18 | 2,132 | 3,099 | $750,373 | $283,512 |
| 2020 | 18 | 1,986 | 2,846 | $547,886 | $161,299 |
Total Patients
4,539
Total Services
6,417
Medicare Billing
$453,865
Procedure Codes
46
All Medicare Procedures & Services
46 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 93010 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | Facility | 2023 | 52 | 57 | $1,570 | $367.95 | 23.4% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 82 | 97 | $7,760 | $2,810 | 36.2% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Office | 2022 | 15 | 15 | $15,225 | $2,290 | 15.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 32 | 35 | $4,200 | $1,523 | 36.3% |
| 93010 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | Facility | 2022 | 119 | 135 | $3,845 | $869.34 | 22.6% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2022 | 89 | 101 | $6,060 | $664.59 | 11.0% |
| 93296 | Evaluation of single, dual, multiple lead or leadless pacemaker system or implantable defibrillator system, remote up to 90 days | Office | 2022 | 17 | 17 | $1,360 | $272.66 | 20.0% |
| 93294 | Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days | Office | 2022 | 15 | 15 | $1,515 | $256.60 | 16.9% |
| 78492 | Multiple nuclear medicine studies of blood flow in heart muscle at rest and with stress | Office | 2021 | 75 | 76 | $190,000 | $100,498 | 52.9% |
| A9555 | Rubidium rb-82, diagnostic, per study dose, up to 60 millicuries | Office | 2021 | 77 | 156 | $93,400 | $51,293 | 54.9% |
| 93229 | Heart rhythm tracing, computer analysis, physician prescribed transmission of patient-triggered events greater than 24-hour ekg up to 30 days | Office | 2021 | 39 | 39 | $89,700 | $24,633 | 27.5% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 212 | 287 | $34,440 | $20,043 | 58.2% |
| 93306 | Ultrasound examination of heart including color-depicted blood flow rate, direction, and valve function | Office | 2021 | 100 | 105 | $106,575 | $18,043 | 16.9% |
| J2785 | Injection, regadenoson, 0.1 mg | Office | 2021 | 76 | 308 | $23,100 | $14,484 | 62.7% |
| 99212 | Established patient outpatient visit, total time 10-19 minutes | Office | 2021 | 186 | 300 | $24,000 | $13,126 | 54.7% |
| 93306 | Ultrasound examination of heart including color-depicted blood flow rate, direction, and valve function | Facility | 2021 | 105 | 105 | $36,960 | $6,231 | 16.9% |
| 93015 | Exercise or drug-induced heart and blood vessel stress test with ekg monitoring, physician supervision, interpretation, and report | Office | 2021 | 98 | 103 | $38,934 | $5,993 | 15.4% |
| 93010 | Routine electrocardiogram (ekg) using at least 12 leads with interpretation and report | Facility | 2021 | 646 | 858 | $25,330 | $5,708 | 22.5% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 40 | 40 | $12,000 | $5,197 | 43.3% |
| 93000 | Routine ekg using at least 12 leads including interpretation and report | Office | 2021 | 279 | 420 | $25,200 | $4,794 | 19.0% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2021 | 30 | 32 | $8,000 | $3,635 | 45.4% |
| 93880 | Ultrasound scanning of blood flow (outside the brain) on both sides of head and neck | Office | 2021 | 17 | 17 | $11,900 | $2,990 | 25.1% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 30 | 37 | $7,400 | $2,181 | 29.5% |
| 93296 | Remote evaluations of single, dual, or multiple lead pacemaker system or implantable defibrillator system with technician review, support and distribution of results, up to 90 days | Office | 2021 | 39 | 91 | $7,280 | $1,883 | 25.9% |
| 93294 | Remote evaluations of single, dual, or multiple lead pacemaker system with qualified health care professional analysis, review, and report, up to 90 days | Office | 2021 | 33 | 75 | $7,575 | $1,730 | 22.8% |
About Dr. Robert Borkowski, MD
Dr. Robert Borkowski, MD is a Cardiovascular Disease healthcare provider based in New Britain, Connecticut. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/25/2006. The National Provider Identifier (NPI) number assigned to this provider is 1801852074.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Robert Borkowski, MD has received a total of $12,697 in payments from pharmaceutical and medical device companies, with $24.52 received in 2023. These payments were reported across 792 transactions from 36 companies. The most common payment nature is "Food and Beverage" ($12,620).
As a Medicare-enrolled provider, Borkowski has provided services to 4,539 Medicare beneficiaries, totaling 6,417 services with total Medicare billing of $453,865. Data is available for 4 years (2020–2023), covering 46 distinct procedure/service records.
Ad
Practice Information
- Specialty Cardiovascular Disease
- Other Specialties Interventional Cardiology
- Location New Britain, CT
- Active Since 04/25/2006
- Last Updated 09/30/2015
- Taxonomy Code 207RC0000X
- Entity Type Individual
- NPI Number 1801852074
Products in Payments
- XARELTO (Drug) $2,170
- Vascepa (Drug) $1,103
- ENTRESTO (Drug) $1,046
- ELIQUIS (Drug) $860.41
- Veltassa (Drug) $540.86
- CardioMEMS HF System (Device) $514.80
- JARDIANCE (Drug) $486.62
- Repatha (Biological) $453.30
- NEXLETOL (Drug) $386.83
- LifeVest (Device) $369.65
- ONPATTRO (Drug) $362.48
- Livalo (Drug) $338.18
- NORTHERA (Drug) $336.67
- PRADAXA (Drug) $324.93
- BYSTOLIC (Drug) $296.95
- CHANTIX (Drug) $232.73
- BRILINTA (Drug) $225.68
- PRALUENT (Drug) $203.93
- VYNDAQEL (Drug) $195.58
- FARXIGA (Drug) $175.43
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Cardiovascular Disease Doctors in New Britain
Justin Lundbye, M.d, M.D
Cardiovascular Disease — Payments: $31,599
Cardiovascular Disease $31,599
Robert Malkin, Md, MD
Cardiovascular Disease — Payments: $18,479
Cardiovascular Disease $18,479
James St Pierre, Md, MD
Cardiovascular Disease — Payments: $16,130
Cardiovascular Disease $16,130
Manny Katsetos, M.d, M.D
Cardiovascular Disease — Payments: $12,050
Cardiovascular Disease $12,050
Jonathan Winkler, M.d, M.D
Cardiovascular Disease — Payments: $6,901
Cardiovascular Disease $6,901
Dr. Jared Insel, M.d, M.D
Cardiovascular Disease — Payments: $6,648
Cardiovascular Disease $6,648